At what age and dose is melatonin (melatonin) considered safe?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Melatonin Safety and Dosing by Age Group

Melatonin is considered safe for children ages 6 and older at appropriate weight-based dosing, with 0.15 mg/kg showing optimal results for children without comorbidities and 3-5 mg for children with psychiatric comorbidities. 1

Safety Profile by Age Group

Children (6-12 years)

  • For children with Delayed Sleep-Wake Phase Disorder (DSWPD) without comorbidities, melatonin at 0.15 mg/kg (approximately 1.6-4.4 mg) is effective and has a moderate level of evidence 1
  • For children with DSWPD and psychiatric comorbidities (such as ADHD), fast-release melatonin at 3-5 mg is recommended 1
  • Weight-based dosing approach: 3 mg if <40 kg and 5 mg if >40 kg has shown effectiveness 1
  • Timing: Administration 1.5-2 hours before habitual bedtime for optimal effect 1

Adolescents

  • Similar dosing as for children with psychiatric comorbidities: 3-5 mg 2
  • No significant adverse effects have been reported in long-term follow-up studies of adolescents using melatonin 1

Adults

  • Doses of 1-5 mg are typically effective for adults with sleep disorders 2
  • Higher doses up to 10 mg appear safe in short-term use but may increase minor adverse effects such as drowsiness, headache, and dizziness 3

Elderly

  • Doses of 1-6 mg are considered safe and effective 2, 4
  • Lower doses (0.5-6 mg) have shown effectiveness in decreasing sleep latency in elderly insomniacs 4
  • Most effective in elderly who chronically use benzodiazepines or have documented low melatonin levels 4

Safety Considerations

  • No serious adverse reactions have been documented in relation to melatonin use across age groups 1
  • Long-term safety data in children is limited, but available evidence is reassuring 1
  • Potential concerns about effects on reproductive development have not been substantiated in follow-up studies 1
  • A questionnaire-based study assessing Tanner stages in children/adolescents using melatonin (mean dose ~3 mg) for approximately 3 years showed no significant differences in pubertal development compared to non-users 1
  • Acute toxicity studies in animals showed toxic effects only at extremely high doses (>400 mg/kg), thousands of times higher than recommended human doses 5

Common Side Effects

  • Mild side effects may include drowsiness, headache, and dizziness 3
  • Gastrointestinal upset has been reported at higher doses 1
  • Morning sleepiness may occur in some children 1

Important Caveats and Recommendations

  • Melatonin is regulated as a dietary supplement, not a medication, raising concerns about purity and reliability of stated doses 1
  • Choose United States Pharmacopeial Convention Verified formulations when possible for more reliable dosing 1
  • Melatonin should be used with caution in patients taking warfarin or those with epilepsy due to potential interactions 1
  • Periodic reassessment is recommended; consider stopping treatment at least once a year to reassess need 5
  • No data supports melatonin use in children under 2 years of age, and its use in this population is concerning due to lack of safety data 6
  • For children with autism spectrum disorders, melatonin has shown effectiveness for improving sleep duration, latency, and reducing night wakings 1

Algorithm for Melatonin Use

  1. Start with lowest effective dose based on age:

    • Children 6-12 years: 0.15 mg/kg (without comorbidities) or 3 mg (<40 kg)/5 mg (>40 kg) with psychiatric comorbidities 1
    • Adolescents: 3-5 mg 2
    • Adults: 1-5 mg 2
    • Elderly: 0.5-6 mg 4
  2. Administer 1.5-2 hours before desired bedtime 1

  3. Assess response after 1-2 weeks 1

  4. If ineffective and no adverse effects, consider gradual dose increase within recommended range 1

  5. Reassess need periodically and consider annual medication holiday 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.